abrdn plc purchased a new position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 82,450 shares of the company's stock, valued at approximately $2,784,000. abrdn plc owned 0.05% of Tempus AI as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. NEA Management Company LLC increased its position in shares of Tempus AI by 17.8% during the third quarter. NEA Management Company LLC now owns 5,385,979 shares of the company's stock valued at $304,846,000 after buying an additional 813,169 shares during the period. ARK Investment Management LLC lifted its stake in shares of Tempus AI by 355.0% in the 3rd quarter. ARK Investment Management LLC now owns 2,378,157 shares of the company's stock valued at $134,604,000 after purchasing an additional 1,855,459 shares during the period. Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Tempus AI by 1,591.2% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company's stock valued at $68,922,000 after purchasing an additional 1,145,698 shares in the last quarter. Franklin Resources Inc. boosted its position in shares of Tempus AI by 1.0% during the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company's stock valued at $45,920,000 after purchasing an additional 8,387 shares in the last quarter. Finally, Carnegie Investment Counsel bought a new position in Tempus AI in the third quarter worth $7,936,000. 24.22% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages have recently commented on TEM. TD Cowen restated a "buy" rating and set a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Bank of America upped their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a "neutral" rating in a report on Friday, December 13th. Piper Sandler reiterated a "neutral" rating and set a $70.00 target price (up from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. William Blair downgraded Tempus AI from an "outperform" rating to a "market perform" rating in a research note on Wednesday. Finally, Guggenheim assumed coverage on Tempus AI in a research note on Monday, December 9th. They issued a "buy" rating and a $74.00 target price on the stock. Four research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat.com, Tempus AI currently has a consensus rating of "Moderate Buy" and a consensus target price of $58.55.
Check Out Our Latest Research Report on Tempus AI
Tempus AI Stock Performance
TEM traded up $9.87 during midday trading on Thursday, hitting $83.75. 29,103,920 shares of the company traded hands, compared to its average volume of 13,449,800. The company's 50-day moving average is $45.82 and its 200 day moving average is $49.97. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $86.00. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.
Insider Buying and Selling at Tempus AI
In other Tempus AI news, CAO Ryan M. Bartolucci sold 13,770 shares of Tempus AI stock in a transaction on Friday, January 31st. The shares were sold at an average price of $60.00, for a total value of $826,200.00. Following the sale, the chief accounting officer now directly owns 57,237 shares in the company, valued at approximately $3,434,220. The trade was a 19.39 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Andrew Polovin sold 51,504 shares of the stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.39, for a total transaction of $2,183,254.56. Following the transaction, the executive vice president now directly owns 246,085 shares of the company's stock, valued at $10,431,543.15. This trade represents a 17.31 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 2,229,449 shares of company stock valued at $102,293,124.
Tempus AI Profile
(
Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
